Trials / Completed
CompletedNCT00649909
Effect of Glucose Control on the Response to Aspirin in Type 2 Diabetic Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The efficacy of low dose aspirin appears to be substantially lower in diabetic patients, compared to patients without diabetes. We will perform an observational study where we follow up patients with uncontrolled type 2 Diabetes Mellitus and low response to aspirin (Aspirin Resistance), during a period of 6 months in the diabetic clinic. Our hypothesis is that glucose control will improve the response to aspirin in those patients.
Conditions
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2008-04-01
- Last updated
- 2017-08-10
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00649909. Inclusion in this directory is not an endorsement.